DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Total Debt Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual total debt in 2023 was 2.53 Million TWD , up 2551.94% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly total debt in 2024 Q2 was 6.24 Million TWD , down -9.18% from previous quarter.
  • DIVA Laboratories, Ltd. reported annual total debt of 283 Thousand TWD in 2022, down -31.14% from previous year.
  • DIVA Laboratories, Ltd. reported annual total debt of 411 Thousand TWD in 2021, down -23.46% from previous year.
  • DIVA Laboratories, Ltd. reported quarterly total debt of - TWD for 2024 Q3, down -10.17% from previous quarter.
  • DIVA Laboratories, Ltd. reported quarterly total debt of 6.87 Million TWD for 2024 Q1, up 171.6% from previous quarter.

Annual Total Debt Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Total Debt of DIVA Laboratories, Ltd. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 2.53 Million TWD 2551.94%
2022 283 Thousand TWD -31.14%
2021 411 Thousand TWD -23.46%
2020 537 Thousand TWD 2457.14%
2019 21 Thousand TWD 0.0%

Peer Total Debt Comparison of DIVA Laboratories, Ltd.

Name Total Debt Total Debt Difference
BIONET Corp. 45.01 Million TWD 94.375%
Genetics Generation Advancement Corp. 49.29 Million TWD 94.864%
Welgene Biotech Co.,Ltd. 154.34 Million TWD 98.36%
Puriblood Medical Co., Ltd. 51.64 Million TWD 95.097%
TFBS Bioscience Inc. 131.77 Million TWD 98.078%